Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 239

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

Open access
Walsh, Thomas J., Adamson, Peter C., Seibel, Nita L., Flynn, Patricia M., Neely, Michael N., Schwartz, Cindy, Shad, Aziza, Kaplan, Sheldon L., Roden, Maureen M., Stone, Julie A., Miller, Alisha, Bradshaw, Susan K., Li, Susan X., Sable, Carole A., Kartsonis, Nicholas A. · 2005 · Antimicrobial Agents and Chemotherapy

Abstract

Caspofungin is a parenteral antifungal that inhibits beta-1,3- d -glucan synthesis. Although licensed for adult use, the appropriate caspofungin dosing regimen in pediatric patients is not yet known. We therefore investigated the pharmacokinetics and safety of caspofungin in pediatric patients. Thirty-nine children (ages 2 to 11 years) and adolescents (ages 12 to 17 years) with neutropenia were administered caspofungin using either a weight-based regimen (1 mg/kg of body weight/day) or a body surface area regimen (50 mg/m 2 /day or 70 mg/m 2 /day). Plasma samples for caspofungin profiles were collected on days 1 and 4. These results were compared to those from adults treated with either 50 or 70 mg/day for mucosal candidiasis. In children receiving 1 mg/kg/day (maximum, 50 mg/day), the area under the concentration-time curve over 24 h (AUC 0-24 ) was significantly smaller (46% after multiple doses) than that observed in adults receiving 50 mg/day ( P < 0.001). In children and adolescents receiving 50 mg/m 2 /day (maximum, 70 mg/day), the AUC 0-24 following multiple doses was similar to that for the exposure in adults receiving 50 mg/day. The AUC 0-24 and concentration trough (at 24 h) in pediatric patients receiving the 50-mg/m 2 daily regimen were consistent across the range of ages. Caspofungin was generally well tolerated in this study. None of the patients developed a serious drug-related adverse event or were discontinued for toxicity. These results demonstrate that caspofungin at 1 mg/kg/day in pediatric patients is suboptimal. Caspofungin administration at 50 mg/m 2 /day provides a comparable exposure to that of adult patients treated with 50 mg/day.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/aac.49.11.4536-4545.2005

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 239

Metadata

Authors
Walsh, T. J., Adamson, P. C., Seibel, N. L., Flynn, P. M., Neely, M. N., Schwartz, C., Shad, A., Kaplan, S. L., Roden, M. M., Stone, J. A., Miller, A., Bradshaw, S. K., Li, S. X., Sable, C. A., & Kartsonis, N. A.
Venue
Antimicrobial Agents and Chemotherapy
Published
2005-11
Volume
49
Issue
11
Pages
4536-4545
ISSN
  • 0066-4804 (ISSN-L)
  • 1098-6596
OpenAlex
W2114146849
Cited by
239
References
5
FWCI
12.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents. https://app.cochat.ai/papers/10.1128/aac.49.11.4536-4545.2005
The paper
Walsh, T. J., Adamson, P. C., Seibel, N. L., Flynn, P. M., Neely, M. N., Schwartz, C., Shad, A., Kaplan, S. L., Roden, M. M., Stone, J. A., Miller, A., Bradshaw, S. K., Li, S. X., Sable, C. A., & Kartsonis, N. A. (2005). Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.49.11.4536-4545.2005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.